Diabetes Flashcards

1
Q

How do we diagnose diabetes?

A
  • requires two of the following:
  • a fasting glucose greater than 7.0 mmol/L (125 mg/dL)
  • a glucose level greater than 11.1 mmol/L (200 mg/dL) two hours after a glucose tolerance test (GTT) is given
  • a random glucose greater than 11.1 mmol/L
  • an HbA1C greater than or equal to 6.5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms of Hyperglycemia vs. Symptoms of Hypoglycemia

A
  • hyperglycemia: weakness, polyuria, polydipsia, dehydration, altered vision, weight loss (prolonged: Kussmaul hyperventilation, coma, arrhythmia)
  • hypoglycemia: palpitations, tachycardia, diapharesis, anxiety, nausea, hyperventilation (prolonged: confusion, behavioral changes, seizures, coma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Somogyi syndrome?

A
  • a rebound hyperglycemia in response to initial hypoglycemia (AKA post-hypoglycemia hyperglycemia); due to a stress reaction by the body in response to prolonged hypoglycemia, triggering glucagon and stress hormone release to increase BGLs
  • occurs in patients taking insulin
  • classic situation: insulin taken at night leads to elevated blood glucose levels in the morning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is type I DM? When and how does it classically present?

A
  • autoimmune destruction of beta cells via T-cells (type IV), resulting in insulin deficiency and hyperglycemia
  • presents in childhood (peak age is 10-14) with hyperglycemia, weight loss, low muscle mass, polyphagia, polyuria, polydipsia, and glycosuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is T1DM associated with?

A
  • genetic association with HLA-DR3 and HLA-DR4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a major complication of T1DM? When can it often arise? What are the clinical features?

A
  • diabetic ketoacidosis (DKA) via an excessive serum level of ketoacids
  • often arises during stress (infection, etc) due to elevated epinephrine levels, which increases glucagon secretion
  • clinical features: hyperglycemia, anion gap metabolic acidosis, hyperkalemia, Kussmaul breathing, acetone breath, mental status changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain the development of hyperkalemia in a patient with DKA.

A
  • insulin helps drive K+ into cells to keep serum levels low, so without it, K+ has a tendency to stay outside
  • in acidosis, the body is trying to get rid of the acid and increases H+ cell uptake to do so; when H+ comes in, K+ goes out
  • serum level of K+ therefore increases, HOWEVER, the total body store of K+ is being depleted, as large amounts of the K+ in the serum will be lost in the urine via osmotic diuresis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do we treat DKA?

A
  • with fluids, insulin, and electrolyte replacement (especially K+!)
  • when we give the patient insulin, cells will quickly take back up the K+ they lost and the serum K+ level will plummet = risk for arrhythmia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is type II DM? What causes it? How does it usually present? Are patients insulin dependent?

A
  • (more common type of DM)
  • end-organ resistance to insulin results in hyperglycemia
  • obesity results in a loss of insulin receptors
  • usually is quite silent, but polyuria, plydipsia, and hyperglycemia are common
  • initially, patients are not insulin dependent as they are producing insulin (they just can’t use it effectively), but as the disease progresses the beta cells burn out and stop producing insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which type of diabetes is more common? Which has a stronger genetic component?

A
  • type II DM is more common

- believe it or not, type II has a stronger genetic component!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a major complication of T2DM?

A
  • hyperosmolar non-ketonic coma (HHS: hyperosmotic hyperglycemic state)
  • this is a state of extremely high BGL (over 500 mg/dL; 28 mmol/L), resulting in life-threatening diuresis due to hypotension and coma
  • ketones are NOT present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are two major complications of hyperglycemia?

A
  • non-enzymatic glycosylation of vasculature

- osmotic damage to the cell types that can take up sugar without insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Non-Enzymatic Glycosylation

A
  • a result of chronic hyperglycemia
  • results in atherosclerosis of large vessels (cardiac problems/IHD, gangrene/amputation/PVD, stroke) and hyaline arteriosclerosis of small vessels (retinopathy, neuropathy, nephropathy)
  • (N.E.G. of Hb results in HbA1C, so this test tests for the state of glycosylation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Osmotic Damage

A
  • a result of chronic hyperglycemia
  • occurs in cells that do not rely on insulin to take up glucose from the blood: Schwann cells (neuropathy), cells of the lens (cataracts), pericytes of retinal blood vessels (blindness)
  • in these cells, excess glucose is converted into sorbitol via aldose reductase; sorbitol is highly osmotic and drags in tons of water that causes the damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which five things is diabetes a leading cause of?

A
  • blindness, MI, stroke, renal failure, and gangrene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do we screen for T1DM?

A
  • C-peptide levels, ICA (islet cell antibodies), IAA (insulin auto-antibodies)
17
Q

What is LADA?

A
  • latent autoimmune diabetes in adults (AKA DM type 1 1/2)

- a much slower pathogenesis of type I DM that presents in adults (is therefore commonly mistaken for T2DM)

18
Q

What is MODY?

A
  • maturity onset diabetes of the young AKA “monogenic diabetes”
  • due to monogenic mutations in autosomal dominant genes
19
Q

Compare serum levels in type 1 DM and type 2 DM.

A
  • T1DM: auto-antibodies, decreased C-peptide, decreased pH, decreased HCO3-, increased ketones
  • T2DM: no auto-antibodies, normal C-peptide, normal pH, normal HCO3-
20
Q

What is the earliest clinical sign of diabetic nephropathy?

A
  • microalbuminuria
21
Q

What are the major goals in the management of diabetes?

A
  • keep fasting glucose levels between 5-7 mmol/L, post-prandial levels less than 10 mmol/L, HbA1C levels between 6.5-7%
  • prevent complications (IHD, PVD, retinopathy, etc.)
22
Q

Treatments for T1DM

A
  • insulin!

- side effects: hypoglycemia, weight gain, issues at injection site

23
Q

Treatments for T2DM

A
  • metformin, thiazolidinediones (not used anymore), sulfonylureas, incretins, SGLT-2 inhibitors
  • insulin
24
Q

Metformin

A
  • used to treat T2DM; 1st line treatment
  • a biguanide; exact mechanism unknown; decreases gluconeogenesis, increases glycolysis and increases insulin sensitivity (peripheral glucose uptake)
  • does not require islet function
  • side effects: lactic acidosis, GI upset, nausea, B12 deficiency
25
Q

Sulfonylureas

A
  • used to treat T2DM; 2nd line agents
  • bind to and block the K+ channels of pancreatic beta cells to stimulate insulin secretion (requires islet function)
  • side effects: hypoglycemia, weight gain
26
Q

Incretins

A
  • used to treat T2DM; 2nd and 3rd line agents
  • GLP-1 analogs and DPP-IV inhibitors (DPP-IV breaks down GLP)
  • potentiates insulin secretion in response to oral glucose (these require glucose, so they don’t have the hypoglycemia side effect of direct insulin and sulfonylurea)
  • increases insulin and decreases glucagon release
27
Q

SGLT-2 Inhibitors

A
  • used to treat T2DM
  • “-agliflozin”
  • does NOT require a pancreas to work; simply blocks glucose reabsorption in the kidneys
  • side effect: genital infections (b/c urine becomes more sugary)
  • DO NOT GIVE TO T1DM PATIENTS (b/c of DKA)
28
Q

” -agliflozin “

A
  • SGLT-2 inhibitors